BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 36517084)

  • 1. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
    Vogl UM; Bojic M; Lamm W; Frischer JM; Pichelmayer O; Kramer G; Haitel A; Kitz K; Harmankaya K; Zielinski CC; Schmidinger M
    BMC Cancer; 2010 Sep; 10():480. PubMed ID: 20819239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study.
    Internò V; Massari F; Rudà R; Maiorano BA; Caffo O; Procopio G; Bracarda S; Atzori F; Passarelli A; Bersanelli M; Stellato M; Fornarini G; Galli L; Ortega C; Zanardi E; Incorvaia L; Facchini G; Giron Berrios JR; Ricotta R; Santoni M; Funaioli C; Trerotoli P; Porta C; Rizzo M
    ESMO Open; 2023 Aug; 8(4):101598. PubMed ID: 37467658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
    Derks SHAE; van der Meer EL; Joosse A; de Jonge MJA; Slagter C; Schouten JW; Hoop EO; Smits M; van den Bent MJ; Jongen JLM; van der Veldt AAM
    Int J Cancer; 2024 May; ():. PubMed ID: 38703351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
    Duarte C; Hu J; Beuselinck B; Panian J; Weise N; Dizman N; Collier KA; Rathi N; Li H; Elias R; Martinez-Chanza N; Rose TL; Harshman LC; Gopalakrishnan D; Vaishampayan U; Zakharia Y; Narayan V; Carneiro BA; Mega A; Singla N; Meguid C; George S; Brugarolas J; Agarwal N; Mortazavi A; Pal S; McKay RR; Lam ET
    EClinicalMedicine; 2023 Jun; 60():102018. PubMed ID: 37304495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
    Gouton E; Gilabert M; Launay S; Loir E; Tyran M; Rochigneux P; Turrini O; Garnier J; Mitry E; Chanez B
    Front Oncol; 2023; 13():1326676. PubMed ID: 38260832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
    Bourlon MT; Remolina-Bonilla YA; Acosta-Medina AA; Saldivar-Oviedo BI; Perez-Silva A; Martinez-Ibarra N; Castro-Alonso FJ; Martín-Aguilar AE; Rivera-Rivera S; Mota-Rivero F; Pérez-Pérez P; Díaz-Alvarado MG; Ruiz-Morales JM; Campos-Gómez S; Martinez-Cannon BA; Lam ET; Sobrevilla-Moreno N
    Front Oncol; 2023; 13():1229016. PubMed ID: 38044992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of asymptomatic brain metastases in metastatic nonsquamous nonsmall cell lung cancer: Treatment implications for resource-constrained settings.
    Shukla S; Prasad KT; Ahuja CK; Muthu V; Singh N
    Indian J Cancer; 2023 Dec; ():. PubMed ID: 38078444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Metastases from Colorectal Cancer: A Systematic Review of the Literature and Meta-Analysis to Establish a Guideline for Daily Treatment.
    Müller S; Köhler F; Hendricks A; Kastner C; Börner K; Diers J; Lock JF; Petritsch B; Germer CT; Wiegering A
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis.
    Semenescu LE; Tataranu LG; Dricu A; Ciubotaru GV; Radoi MP; Rodriguez SMB; Kamel A
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention.
    Bishop AJ; Zheng J; Subramaniam A; Ghia AJ; Wang C; McGovern SL; Patel S; Guadagnolo BA; Mitra D; Farooqi A; Reardon MJ; Kim B; Guha-Thakurta N; Li J; Ravi V
    Am J Clin Oncol; 2022 Jun; 45(6):258-263. PubMed ID: 35588225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?
    Parikh M
    J Kidney Cancer VHL; 2021; 8(4):20-21. PubMed ID: 34722127
    [No Abstract]   [Full Text] [Related]  

  • 12. Contemplation of the Effect of Nivolumab Plus Cabosantinib Therapy on Cerebral Hemorrhage in Patients with Brain Metastasis of Renal Cell Carcinoma: A Case Report.
    Sato Y; Kawasaki Y; Satake Y; Shimoda Y; Katayama H; Sato T; Shimada S; Kawamorita N; Yamashita S; Kanamori M; Ito A
    Case Rep Oncol; 2023; 16(1):1573-1578. PubMed ID: 38089733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Systemic Therapy in Metastatic Renal-Cell Carcinoma Patients With Synchronous and Metachronous Brain Metastases.
    Parmar A; Soliman H; Sahgal A; Bjarnason GA
    Clin Genitourin Cancer; 2020 Jun; 18(3):e224-e232. PubMed ID: 32139300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
    Ha FJ; Spain L; Dowling A; Kwan EM; Pezaro C; Day D; Chia PL; Tran B; Pook D; Weickhardt AJ
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e97-e102. PubMed ID: 30701671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.
    Wardak Z; Christie A; Bowman A; Stojadinovic S; Nedzi L; Barnett S; Patel T; Mickey B; Whitworth T; Hannan R; Brugarolas J; Timmerman R
    Clin Genitourin Cancer; 2019 Apr; 17(2):e273-e280. PubMed ID: 30595522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
    Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
    Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.
    Lee HW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
    Parmar A; Ghosh S; Sahgal A; Lalani AA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger C; Soulières D; Breau RH; Tanguay S; Kapoor A; Pouliot F; Bjarnason GA
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1763. PubMed ID: 36517084
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.